Related Experiment Videos

Cerebellar atrophy: an important feature of carbohydrate deficient glycoprotein syndrome type 1

H Antoun1, N Villeneuve, A Gelot

  • 1Service de Radiopédiatrie, Hôpital St Vincent de Paul, Paris, France.

Pediatric Radiology
|April 14, 1999
PubMed

Insights

Carbohydrate-deficient glycoprotein syndrome type 1 (CDGS 1) can cause cerebellar atrophy in children under two. Early diagnosis via MRI and biological tests is crucial for managing this rare metabolic disorder.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • Carbohydrate-deficient glycoprotein syndrome type 1 (CDGS 1) is a rare autosomal recessive metabolic disorder.
  • CDGS 1 affects multiple systems due to defects in glycoprotein synthesis.
  • Cerebellar atrophy is a potential neurological complication.

Observation:

  • Three children under two years old presented with cerebellar atrophy.
  • One patient exhibited multisystem disease; two had mental retardation and ataxia.
  • Cerebellar atrophy predominantly involved the anterior lobe.

Findings:

  • Magnetic resonance imaging (MRI) diagnosed cerebellar atrophy in all cases.
  • Autopsy confirmed cerebellar atrophy in one patient.
  • Vertical tentorium cerebelli orientation suggested antenatal onset in two cases.
  • Biological tests confirmed CDGS 1 diagnosis.

Implications:

  • Early identification of CDGS 1 is vital for pediatric neurological care.
  • MRI is a key diagnostic tool for detecting cerebellar atrophy in CDGS 1.
  • Understanding antenatal disease onset aids in prognosis and management strategies.

Related Concept Videos